Connect with us
  • Elysium


NR headlines: Thursday 23rd May

Welcome to your daily round up of everything happening in the world of neurorehab.



Welcome to your daily round up of everything happening in the world of neurorehab.


Extreme temperatures may increase risk of stroke mortality

Extreme heat and extreme cold are both associated with increased risks of death from ischemic and hemorrhagic stroke, according to a new study led by Harvard T.H. Chan School of Public Health. The researchers found that the link between extreme temperatures and stroke mortality was stronger in low-income countries than in high-income countries.


Regular fish oil supplement use might boost first time heart disease and stroke risk

Regular use of fish oil supplements might increase, rather than lessen, the risk of first time heart disease and stroke among those in good cardiovascular health, but may slow progression of existing poor cardiovascular health and lower the risk of death, suggest the results of a large long term study, published in the open access journal BMJ Medicine.


World-first brain pacemaker for drug-resistant epilepsy 

A world-first minimally invasive brain pacemaker is now available on the NHS for drug-resistant epilepsy patients across the UK. Developed by medtech company, Precisis, EASEE – Epicranial Application of Stimulation Electrodes for Epilepsy, is a system for individualised brain stimulation that is anatomically precisely positioned over the epileptic focus in the brain and surgically placed just under the scalp.

Based on a dual principle of action, EASEE provides a disruptive, acute effect with high-frequency pulses every two seconds against emerging seizures and direct current-like phases applied every day for 20 minutes, which regulate over-excitable brain areas in the long term to prevent seizures.

AI could be new weapon in fight against dementia 

Dementia-related disorders such as Alzheimer’s and Parkinson’s arise when some of the smallest building blocks in the body clump together and destroy vital functions. Researchers from the Hatzakis lab at the University of Copenhagen’s Department of Chemistry have invented a machine learning algorithm that can track clumping under the microscope in real-time. The algorithm can automatically map and track the important characteristics of the clumped-up building blocks that cause Alzheimer’s and other neurodegenerative disorders. Until now, doing so has been impossible.

Company updates 

Temple Street Biotech initiates therapeutic antibody for Alzheimer’s

Temple Street Biotech has announced the initiation of a pioneering therapeutic antibody targeting prion protein for the treatment of Alzheimer’s disease, in collaboration with a highly respected Clinical Research Organisation. The antibody aims to interrupt the binding process between amyloid-beta (A-β) oligomers and hippocampal nerve cells, potentially reducing plaque formation and its associated memory damage, representing a significant step forward in the fight against Alzheimer’s. 

Nexalin joins National Traumatic Brain Injury (TBI) Registry Coalition

Nexalin America has been selected to join the National Traumatic Brain Injury (TBI) Registry Coalition, dedicated to advancing research, raising public awareness, and supporting clinical trials that address traumatic brain injuries. The move represents a unified alliance of both private sector entities and non-profit organisations committed to fostering the development of a national TBI registry.